0001209191-17-002803.txt : 20170106
0001209191-17-002803.hdr.sgml : 20170106
20170106210714
ACCESSION NUMBER: 0001209191-17-002803
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170104
FILED AS OF DATE: 20170106
DATE AS OF CHANGE: 20170106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immune Design Corp.
CENTRAL INDEX KEY: 0001437786
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262007174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1616 EASTLAKE AVE. E
STREET 2: SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 682-0645
MAIL ADDRESS:
STREET 1: 1616 EASTLAKE AVE. E
STREET 2: SUITE 310
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: VACCSYS INC
DATE OF NAME CHANGE: 20080617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BALTIMORE DAVID
CENTRAL INDEX KEY: 0001185858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36561
FILM NUMBER: 17515594
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-04
0
0001437786
Immune Design Corp.
IMDZ
0001185858
BALTIMORE DAVID
CIO IMMUNE DESIGN CORP.
1616 EASTLAKE AVE. E., SUITE 310
SEATTLE
WA
98102
1
0
0
0
Stock Option (right to buy)
5.60
2017-01-04
4
A
0
10000
0.00
A
2027-01-04
Common Stock
10000
10000
D
The shares underlying the option will become fully vested on January 4, 2018, subject to the Reporting Person's continuous service through such
date.
/s/ Stephen R. Brady, Attorney-in-Fact
2017-01-06